AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract W9113M10C0057ARBUTUS BIOPHARMA CORPORATION
Overview
Award facts
- Net obligations
- $52.19M
- $52,187,135of $157.23M potential value
- Period of performance
- Jan 22, 2018 to Jan 29, 2016
- Ended
- Modifications
- 45
- Latest action Jan 22, 2018
- Contract type
- Definitive contract
- PIID W9113M10C0057
Description of requirement
ADVANCED DEVELOPMENT OF HEMORRHAGIC
Dates and value
- Award date
- Signed on Jul 14, 2010
- Potential end of performance
- Oct 2, 2016
- Current value
- $122,547,197Base and exercised options
- Potential value (if all options are exercised)
- $157,226,529
Obligations by fiscal year of action
- FY2018: -$559,672 (de-obligation)
- FY2016: -$17,185,180 (de-obligation)
- FY2015: $26,112,861
- FY2014: $2,100,000
- FY2013: $15,860,434
- FY2012: $8,550,000
- FY2011: $7,553,366
- FY2010: $9,755,326
Total across 8 fiscal years: $52,187,135
Net de-obligation in that fiscal year (obligations withdrawn).
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 20, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 22, 2018. View on USAspending · Recipient on SAM.gov
Recipient
LocationBURNABY, CAN
UEIZ6GEANC7LJP1
Business sizeOther than small businessSize at award, per the contracting officer
Parent companyARBUTUS BIOPHARMA CORPORATION
Business types and certifications
Foreign-ownedFor-profit organizationTax-exempt corporationManufacturer of goods
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Department Of The Army
- W6QK ACC-APG NATICK
- Funded by
- Department of Defense
- Department Of The Army
- W6DZ JPMO CBD JPMO MCS (06)
Place of performance
- Place of performance
- Canada
Classification and competition
Classification
- Product or service (PSC)
- AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus incentive feeV
- Offers received
- 10
Solicitation and notices
- Solicitation ID
- W9113M09R0008
- Notices
- Presolicitation posted Sep 21, 2009
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jul 14, 2010Base obligation at award: $9,755,326
- Latest action
- Jan 22, 2018 — Other administrative actionModification P00044; administrative: no change in scope or value
- Latest substantive action
- May 26, 2015 — Change orderModification P00037; obligation change +$1,690,592
- Latest funding action
- Jan 20, 2016 — Funding onlyModification P00042; obligation change -$17,185,180; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Supplemental agreement (within scope)15
- Funding only13
- Other administrative action11
- Change order4
- Option exercised1
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- Foreign-owned business not incorporated in the U.S.D
- Country of product or service origin
- CanadaCAN
- Place of manufacture
- Not a manufactured end productC
- Sea transportation
- No
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- DoD claimant program
- Medical and dental supplies and equipmentC9B
- Awarding agency code
- 9700
- Awarding sub-tier code
- 2100
- Contracting office code
- W911QY
- Transactions recorded under this award key
- 45
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 2100
- Funding office code
- W56XNH